I'm moving in that direction. Every day makes it

I'm moving in that direction. Every day makes it more likely IMO. I'd say I'm 54/46 EUA for M2M.

But I was thinking about something last night. The UK process could take some time. Don't know how long yet, but let's say 6 weeks. And let's assume the worst regarding m2m, and assume we get a phase 3.

Sky is falling, right?

Share price prob takes a hit. Oh no uplist is in jeopardy!

Not so fast. We are looking at having our interim analysis completed in 4-5 weeks. I believe this data will not only be statistically significant,but will also be much easier for the media and population to understand. If we reduce mortality by say 66%, I expect that news to travel very quickly. The pressure for EUA will be immense.

It's entirely possible that all of the things we are doing right now are actually in preparation for that day. It's also very likely that the DSMC review actually gave the fda a heads up as to what is coming.

So, my point is that I think on the outside, we are probably looking at 6 weeks or so. I hope it's sooner, but I feel pretty confident that the range of outcomes is narrowing.

All IMO of course.